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The defense against mucosal infections relies on chemokines
that recruit inflammatory cells to the mucosa. This study
examined if the chemokine response to uro-pathogenic
Escherichia coli is influenced by fimbrial expression. The CXC
(CXCL1, CXCL5, CXCL8, CXCL9, CXCL10) and CC chemokines
(CCL2, CCL3, CCL5) were quantified after in vitro infection of
uro-epithelial cells with a fimbriated E. coli pyelonephritis
isolate, or with P or type 1 fimbriated transformants of an
avirulent E. coli K-12 strain. The response profile was shown
to vary with the fimbrial type. Type 1 fimbriated E. coli
elicited mainly CXCL1 and CXCL8, whereas P fimbriated E. coli
stimulated CCL2 and CCL5 and class II were more potent
chemokine inducers than class III P fimbriae. Chemokines
were also quantified in urine samples from 73 patients with
febrile urinary tract infection, and analyzed as a function of
disease severity and fimbrial expression by the strain
infecting each patient. A complex CXC and CC chemokine
response was detected in patient urine, with a significant
influence of the fimbrial type. The results show that virulence
factors like fimbriae may modify the mucosal chemokine
response. This mechanism may allow the host to adjust the
inflammatory cell infiltrate to fit the infecting strain.
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Pathogens break the inertia of the mucosal barrier and
provoke a rapid innate host response. However, colonization
is not sufficient, as the asymptomatic carrier Escherichia coli
strains establish in large numbers without provoking mucosal
inflammation.1 The host response and the repertoire of
inflammatory mediators are influenced by bacterial virulence
factors, and their distinct molecular interactions with host
cell receptors perturb different signaling pathways in the host
cells.2 Adherence is a key event, which facilitates tissue attack
by a wide range of virulence factors and activates the immune
response. In addition, the bacterial surface adhesins induce
the host response directly, by binding to their respective host
cell receptors.3 Epithelial cells sense the presence of the
bacteria and respond to infection by secreting chemokines,
which enhance the early anti-microbial defense by recruiting
inflammatory cells from the circulation to the mucosa.4–7
Two major subgroups of the chemokine super-family can
be distinguished. The CC chemokines (e.g. MCP-1/CCL2,
MIP-1a/CCL3, and RANTES/CCL5), in general, do not act
on neutrophils but attract monocytes, eosinophils, basophils,
and lymphocytes.8 The CXC chemokines can be further
subdivided depending on the glutamic acid–leucine–arginine
(ELR) sequence. The ELR containing CXC chemokines are
chemotactic for neutrophils (e.g. GRO-a/CXCL1 and IL-8/
CXCL8), whereas those not containing the sequence act on
lymphocytes (e.g. MIG/CXCL9 and IP-10/CXCL10). The
local chemokine repertoire determines the quality of the
inflammatory infiltrate and the effector functions important
for the host defence. Epithelial chemokines may thus
influence the composition of the inflammatory infiltrate
hereby affecting the recruitment of cell populations to the
mucosa.
Uro-pathogenic E. coli (UPEC) associated with pyelone-
phritis provoke a rapid inflammatory response in the urinary
tract mucosa. The most virulent UPEC strains express P
fimbriae, which recognize glycosphingolipid receptors
through their PapG tip adhesin.9,10 The coupling of P
fimbriae to the Gala1-4Galb-receptor epitopes stimulates
uro-epithelial cells to synthesize several cytokines, including
interleukin-6 and CXCL8.11,12 Type 1 fimbriae are expressed
both by UPEC strains and commensals,13,14 but still type 1
fimbriae have been proposed to play a critical role for the
persistence of E. coli in the murine urinary tract15,16 through
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an interaction with cells lining the bladder mucosa.3,17 Type 1
fimbriae recognize N-linked mannose residues in a wide
range of glycoproteins, including the Tamm-Horsfall glyco-
protein in urine and the cell bound uroplakin Ia, which is
expressed in the bladder but not in the renal pelvis.18 In
previous studies, binding of type 1 fimbriated E. coli to uro-
epithelial cells was shown to stimulate a cytokine response
that was inhibited by soluble receptor analogues19 and the
fimbriae were shown to stimulate epithelial CXCL8 expres-
sion in vitro.4,6 However, the influence of fimbriae on the
mucosal chemokine response repertoire has not been
investigated.
This study compared mucosal chemokine response to P or
type 1 fimbriated E. coli, using human uro-epithelial cells as
an in vitro model. The effect of fimbrial expression on the
chemokine repertoire in vivo was also examined in patients
with febrile urinary tract infection (UTI). The results show
that the fimbrial type influences the magnitude and
repertoire of chemokines and suggest that these interactions
are relevant for human disease.
RESULTS
Epithelial chemokine response to UPEC
In vitro infection of uro-epithelial cell layers was used to
examine if epithelial cells might be a source of the
chemokines in urine. A498 cells were grown on the under
side of Transwell filters, bacteria were added to the lower well,
and chemokine secretion to the upper well was quantified by
enzyme-linked immunosorbent assay. A pyelonephritis E. coli
isolate caused an increase in epithelial chemokine secretion
including CXC (CXCL1, CXCL8, CXCL9, CXCL10) and CC
(CCL2, CCL3, CCL5) chemokines (Table 1a). Changes in
chemokine mRNA levels were quantified by the RNA
protection assay, with primers specific for CXC (CXCL8
and CXCL10) and CC (CCL2–5). Results obtained from
samples taken 2 and 24 h after infection are shown in Table
1b. An increase in CXCL8, CXCL10, CCL2, and CCL5 mRNA
levels was detected 24 h after infection with E. coli Hu734.
Epithelial CXCL8 responses are influenced by E. coli fimbriae
To examine the effect of fimbriation on the epithelial CXCL8
response, non-fimbriated E. coli K-12 strains were trans-
formed with the pap or fim sequences. Secreted CXCL8 was
quantified in supernatants obtained at different times after
infection of the Transwell cell layers infected with fimbriated
or non-fimbriated strains. The fimbriated strains stimulated a
strong CXCL8 response (66 ng/ml for the fimþ and 27 ng/ml
for the papþ ), but the non-fimbriated isogenic controls
failed to activate the cells (2.7 ng/ml for the fim and 2.8 ng/
ml for the papþ ; Po0.001 or Po0.01 in comparison with
Table 1 | E. coli Hu734 infection stimulates chemokine secretion and increases the chemokine mRNA content of uro-epithelial
cells
A498 cells infected with E. coli Hu734 (Mean7s.e.m.)a
Chemokines Before infection After infectionb Po
(a) Secretion (ng/ml)
CXC
CXCL1 0.370.2 17.371.0 0.001
CXCL5 0.070.0 1.070.4 NSc
CXCL8 0.070.0 17.970.9 0.001
CXCL9 0.070.0 29.774.4 0.001
CXCL10 0.070.0 94.776.4 0.001
CC
CCL2 0.470.0 7.971.7 0.001
CCL3 0.970.4 6.270.5 0.001
CCL5 0.070.0 2.770.1 NSc
2 h infection 24 h infection Po
(b) mRNA levels (%)d
CXC
CXCL8 9.074 51.074 0.001
CXCL10 5.074 18.074 0.01
CC
CCL2 26.076 35.072 0.05
CCL3 —e —e —
CCL4 —e —e —
CCL5 4.077 31.073 0.001
ANOVA, analysis of variance; E. coli, Escherichia coli; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
Note: Comparison of chemokines before and after infection was performed with one-way ANOVA and Bonferroni multiple comparisons test.
aMean of four experiments.
bSamples were obtained 24 h after infection.
cNot significant.
dmRNA concentrations are given in percent mRNA of the house-keeping gene (GAPDH) mRNA in each sample.
eNot found.
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the fimþ and papþ strains). The fimþ strain stimulated
higher CXCL8 secretion than the papþ strain (66 and 27 ng/
ml, respectively, Po0.001), and the recombinant strains
triggered higher CXCL8 responses than the clinical isolate
(18.9 ng/ml E. coli Hu734, Po0.001 in comparison with the
fimþ and Po0.01 in comparison with the papþ ).
Influence of fimbriae on the chemokine response repertoire
The chemokine response repertoire was compared after
infection of the Transwell cell layers with E. coli expressing
the different fimbrial types (Table 2a and b, Figure 1). The
papþ strains stimulated higher secretion of the CC
chemokines (CCL2, CCL3, and CCL5) than the fimþ strain.
The fimþ E. coli strain stimulated higher CXC chemokine
responses (mainly CXCL1 and CXCL8) than the papþ
strains, but the CC chemokine levels were lower for the fimþ
as compared to the papþ E. coli strains (Table 2a and b,
Figure 1). The response to type 1 fimbriae was adhesin
dependent, as shown by comparing the responses to the
fimH mutant and the intact fimbriae. In addition, there was
a difference in chemokine response repertoire between strains
expressing the class II or the class III P fimbrial types (Table
2a). The prsþ strain stimulated higher CXCL9 and CCL5
responses than the papþ strain, but remaining chemokine
responses were lower. Surprisingly, the pap or fim strains
induced a higher CXCL10 response than the fimbriated
strains, but they did not trigger other chemokines. The
chemokines CXCL9 and CXCL10 are known to display
defensin-like anti-microbial activities20 and were formed in
response to all of the UPEC strains used, suggesting that the
secretion is independent of the P and type 1 fimbriae.
Chemokine response kinetics
The fimbriae were also shown to influence the kinetics of the
chemokine response in the Transwell model (Figure 2). The
fimþ strain caused a more rapid CXCL8 response than the
papþ strain, but the papþ strain triggered CCL2 and CCL3
levels more rapidly than the fimþ strain. After 24 h
(Figure 2), CXCL8 responses had increased further, but
remained higher in cells infected with the fimþ than with
the papþ strains. Papþ strains had stimulated higher
CXCL5, CCL2, CCL3, and CCL5 responses than the fimþ
strains after 24 h.
Chemokine mRNA profile in relation to fimbrial expression
To investigate if bacteria influence the kinetics of cytokine
mRNA levels in epithelial cells, the CXC (CXCL8 and
CXCL10) and CC (CCL2–5) chemokine mRNAs were
quantified after 2 or 24 h infection by the RNA protection
assay. After 2 h, both the fimþ and the papþ recombinant
strains caused an increase in CXCL8 and CCL2 mRNA levels
(Figure 3), but there was no response to the pap strain, and
a low response to the fim control. CXCL8 mRNA levels
remained high after 24 h in cells exposed to the fimþ strain,
and responses to the remaining recombinant strains had
caught up (Figure 3). CCL2 mRNA levels remained high in
cells exposed to the papþ strain, but decreased for the fimþ
strain. CCL5 mRNA was detected for all recombinant E. coli
strains, but was mostly induced by the prsþ strain.
Pap genotype and disease severity
Patients with febrile UTI (n¼ 73) were enrolled in the study
(Figure 4). The infecting strains were isolated and saved and
the papG alleles were identified by polymerase chain reaction.
Most of the E. coli strains were P fimbriated (51/73, 70%), 33
were papþ (45%), 15 were prsþ (21%), and three strains
expressed both the pap and the prs adhesins. Strains lacking
the pap gene cluster (pap) accounted for 30% of the
infections.
Table 2a | P fimbriated recombinant E. coli strains stimulate chemokine secretion of A498 cell layers
A498 cells infected with recombinant P fimbriated E. coli (Mean7s.e.m.)a
Chemokines (ng/ml) pap+b Poc Pod prs+e Pof papg
CXC
CXCL1 35.377.1 0.001 0.001 0.370.2 NS 0.270.3
CXCL5 1.670.1 0.001 NS 1.570.2 NS 0.170.1
CXCL8 26.672.9 0.001 0.001 0.470.0 0.05 2.870.6
CXCL9 4.973.2 0.01 0.001 14.770.0 0.001 1.871.1
CXCL10 23.379.6 0.001 0.001 47.778.8 NS 50.375.9
CC
CCL2 16.071.2 0.001 0.001 0.570.3 NS 0.870.2
CCL3 0.770.6 NS NS 0.570.3 NS 0.170.0
CCL5 0.570.1 NS 0.001 1.970.3 0.001 0.070.0
ANOVA, analysis of variance; E. coli, Escherichia coli; NS, not significant.
Note: Comparisons of chemokines between the different P fimbriated strains were performed with one-way ANOVA and Bonferroni multiple comparisons test.
aMean of four experiments.
bE. coli HB101(pDC1).
cpap+ compared to pap.
dpap+ compared to prs+.
eE. coli HB101(pHU845).
fprs+ compared to pap.
gE. coli HB101.
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The papþ isolates predominated in patients with normal
urinary tracts, causing 22/27 infections (22/23 in women and
1/4 in men). In contrast, prsþ E. coli occurred mainly in
patients with abnormalities of the urinary tract (11/25 men,
44% and 2/4 women, 50%). The pap strains were also more
common in patients with abnormalities of the urinary tract
(10/25 men, 40% and 2/4 women, 50%).
The focal urinary tract symptoms at inclusion were
analyzed in relation to the papG genotype of the infecting
E. coli strain (Table 3). The papþ E. coli strains caused
symptoms of acute pyelonephritis more often than the prsþ
or the pap isolates (Po0.01). The prsþ isolates, in
contrast, caused infections with symptoms from the lower
urinary tract more often than the papþ or the pap isolates
(Po0.05). However, there were no significant differences in
C-reactive protein, temperature, fever duration, or inter-
leukin-6 concentrations related to the papG allele (Table 4).
Chemokine response to febrile UTI
Chemokine levels were quantified in urine samples obtained
at admission to hospital and during the first 24 h after onset
of treatment. A broad spectrum of chemokines was detected.
These included the CXC chemokines CXCL1 (mean 0.214 ng/
ml, range 0.0–7.40), CXCL5 (mean 0.160 ng/ml, range
Table 2b | Type 1 fimbriated recombinant E. coli strains stimulate chemokine secretion of A498 cell layers
A498 cells infected with recombinant type 1 fimbriated E. coli (Mean7s.e.m.)a
Chemokines (ng/ml) fim+b Poc Pod fimHe Pof fimg
CXC
CXCL1 74.879.5 0.001 0.001 5.571.4 NS 0.870.3
CXCL5 0.170.5 NS NS 0.170.0 NS 0.170.1
CXCL8 65.577.7 0.001 0.001 1.570.5 NS 2.770.5
CXCL9 9.871.7 0.001 0.01 4.972.0 NS 2.271.4
CXCL10 54.176.0 NS 0.01 32.272.9 0.001 69.6710.3
CC
CCL2 1.870.3 0.001 0.001 0.370.1 0.05 0.770.3
CCL3 0.070.0 NS 0.001 1.070.3 0.001 0.170.0
CCL5 0.170.3 NS 0.01 0.970.5 0.001 0.070.0
ANOVA, analysis of variance; E. coli, Escherichia coli; NS, not significant.
Note: Comparisons of chemokines between the different type 1 fimbriated strains were performed with one-way ANOVA and Bonferroni multiple comparisons test.
aMean of four experiments.
bE. coli AAEC191A(pPKL4).
cfim+ compared to fim.
dfim+ compared to fimH.
eE. coli AAEC191A(pPKL114).
ffimH+ compared to E. coli fimH.
gE. coli AAEC191A(pBR322).
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Figure 1 | Chemokine repertoire as a function of fimbrial
expression by the infecting strain. Difference in epithelial
chemokine secretion between (a) papþ and fimþ E. coli or (b)
between papþ and prsþ E. coli. Confluent A498 kidney epithelial
cell layers were exposed to P or type 1 fimbriated recombinant E. coli.
The chemokine secretion was measured in supernatants obtained
from the upper compartment of Transwell units after 24 h.
Mean7s.e.m. values from four independent experiments are shown
(*Po0.05, **Po0.01, ***Po0.001). fimþ ¼ E. coli AAEC191A(pPKL4),
papþ ¼ E. coli HB101(pDC1), prsþ ¼ E. coli HB101(pHU845).
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Figure 2 | Chemokine response kinetics as a function of fimbrial
expression. Confluent A498 kidney epithelial cell layers were
exposed to P or type 1 fimbriated recombinant E. coli. The chemokine
secretion was measured in supernatants obtained from the upper
compartment of Transwell units after 24 h. Values are given in ng/ml
after subtraction of the medium control. The results are
means7s.e.m.s of four separate experiments.
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0.0–1.80), CXCL8 (mean 6.123 ng/ml, range 0.062–652),
CXCL9 (mean 0.172 ng/ml, range 0.0–2.60), CXCL10 (mean
3.611 ng/ml, range 0.0–34.2) and the CC chemokines CCL2
(mean 0.445 ng/ml, range 0.0–19.2), CCL3 (mean 0.183 ng/
ml, range 0.0–1.40), and CCL5 (mean 0.730 ng/ml). Chemo-
kines are not present in urine from healthy individuals.21–23
The results show that febrile UTI is accompanied by a
complex chemokine response.
Influence of the papG genotype on chemokine response
repertoire in vivo
The chemokine concentrations were analyzed as a function of
the papG genotype of the infecting E. coli strain (Table 5,
Figure 2). The papþ E. coli triggered higher CXCL8 (P¼not
significant) and CCL2 (Po0.0001) responses than those
infected with prsþ strains, whereas the prsþ E. coli triggered
higher CCL5 (Po0.05) responses than the papþ strains
(Table 5). Patients infected with pap E. coli had lower urine
CCL2 concentrations than the total group of patients with
papþ E. coli (Po0.01). The results suggested that the
fimbrial receptor specificity influences the chemokine
response in the human urinary tract (Figure 5).
DISCUSSION
Mucosal responses to bacterial infection are multifaceted and
depend on the pathogen as well as the response repertoire of
infected host cells. This study shows that the chemokine
response in the urinary tract is modified by fimbrial
expression. The chemokine repertoire of infected epithelial
cells was shown to vary with the fimbrial type as type 1
fimbriated E. coli mainly provoked a CXCL1 and CXCL8
response, whereas P fimbriae stimulated more CCL2 and
CCL5. The class II P fimbriae induced a higher CXCL8 and
CCL2 response than the class III fimbriae, whereas the class
III P fimbriated E. coli strain stimulated CCL5 more than the
class II fimbriae. Similar differences in chemokine secretion
were observed in patients with febrile UTI where the class II P
fimbriae triggered higher CCL2 responses, whereas the class
III P fimbriated strains induced a CCL5 secretion. The results
illustrate how fimbriae influence the quality of the innate
host response. We speculate that sensing of adhesins may
allow the host tissue to adjust the chemokine repertoire and
the inflammatory cell infiltrate to efficiently combat the
infecting strain.
Adherence of UPEC to mucosal surfaces triggers an
inflammatory response.24–26 It is sufficient to transform a
non-adherent K-12 strain with the pap or fim sequences to
convert it to a potent host response inducer.19 In addition,
the fimbrial adhesins influence the transmembrane signaling
pathways involved in epithelial cytokine responses.11,27 After
binding to glycosphingolipid receptors, P fimbriated E. coli
recruit Toll-like receptor 4 (TLR4) for transmembrane
signaling, independently of lipopolysaccharide and
CD14.28,29 Studies in the murine UTI model have shown
that the P fimbriae utilize the TLR4 adapter molecules Trif/
Tram for signal transduction, rather than the lipopolysac-
charide-related adaptor molecules, MyD88 and Toll inter-
leukin 1 receptor domain-containing adapter protein.30 The
interaction with TLR4 is relevant for the human urinary tract
as TLR4 mRNA is present in kidney epithelial cells3,29 and the
protein is abundantly expressed in human uro-epithelium.31
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Figure 3 | Chemokine mRNA concentrations in A498 epithelial
cells. mRNA was purified from epithelial cells after 2 or 24 h exposure
to E. coli strains differing in P or type 1 fimbrial expression. Individual
chemokine mRNA species were quantified by the RNA protection
assay, using primers specific for CXC and CC chemokine mRNAs.
CXCL8 and CCL2 mRNAs were detected after 2 and 24 h. After 24 h,
a weak CCL5 and CXCL10 signal was observed in some samples.
The figure shows one representative result out of four experiments.
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Figure 4 | Patient characteristics and papG allele distribution in
76 patients with febrile UTI with E. coli. The patients were
subdivided into two groups, depending on health and urinary tract
abnormalities. Papþ strains predominated in patients with normal
voiding, whereas prsþ or pap strains were more common in
patients with urinary tract abnormalities.
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The response to type 1 fimbriated strains is also TLR4
dependent, but involves lipopolysaccharide and the adaptor
molecule MyD88.28,32 The different signaling pathways could
lead to different regulation of transcription factors, that is,
Trif/Tram leads to the activation of interferon regulating
factor-3 first and later nuclear factor-kB, whereas
Table 3 | Focal urinary tract symptoms at inclusion in febrile UTI patients in relation to pap genotypes of the infecting E. coli
Symptoms No. P positive pap+ prs+ pap
All patients, n (%) 73 51 33 15 22
Pyelonephritisa 29 (57) 24 (73)a 4 (27)a 10 (45)
Lower urinary tractb 31 (61) 17 (52)b 13 (87)b 17 (77)
No focal symptoms 9 (18) 6 (18) 2 (13) 3 (14)
E. coli, Escherichia coli; UTI, urinary tract infection.
Note: Comparison of symptoms between the papG alleles with the Fisher’s exact test showed the following differences;
Po0.01 for comparison between entries followed by letter a.
Po0.05 for comparison between entries followed by letter b.
aClinical signs of pyelonephritis; flank pain, costovertebral angle tenderness.
bLower urinary tract symptoms: dysuria, urgency, frequency.
Table 4 | Host response parameters in febrile UTI in the two groups of patients
Healthy women Compromised men
pap+ (n=21) pap+ (n=4) prs+ (n=11) pap (n=10)
Temperature at inclusion, C1 39.6 39.4 39.3 39.5
CRP at inclusion, median 150 152 88 116
CRP maximum, median 206 202 155 152
Fever duration,a days 3 3 2 2.5
Serum IL-6 (ng/ml)
At inclusion 140 46 198 297
Maximum 173 68 198 380
Urine IL-6 (ng/ml)
At inclusion 54 170 42 188
Maximum 120 170 148 188
Urine CCL2 (ng/ml)*
At inclusion 0.62 0.60 0.09 0.14
Maximum 0.49ab 0.34 0.10a 0.11b
CRP, C-reactive protein; IL-6, interleukin-6; UTI, urinary tract infection.
Note: Comparison of the parameters between the different patient groups using Mann–Whitney test showed the following differences:
Po0.05 for comparison between entries followed by letter a.
Po0.01 for comparison between entries followed by letter b.
*No differences were found for the other eight cytokines.
aAfter start of therapy.
Table 5 | Chemokine concentrations in patients with febrile UTI in relation to the pap genotype of the infecting strain
Chemokine concentrationa
Infecting E. coli strain
Chemokines pap+ prs+ Po
CXC ng/ml, mean (range)
CXCL1 0.190 (0–0.827) 0.169 (0–0.568) NS
CXCL5 0.164 (0–1.80) 0.087 (0–0.429) NS
CXCL8 3.581 (0–60.7) 1.547 (0–8.90) NS
CXCL9 0.139 (0–0.521) 0.181 (0–0.442) NS
CXCL10 3.222 (0–12.8) 4.761 (0–18.9) NS
CC ng/ml, mean (range)
CCL2 0.697 (0–19.2) 0.160 (0–0.694) 0.0001
CCL3 0.186 (0–0.717) 0.198 (0–0.442) NS
CCL5 0.126 (0–0.864) 0.280 (0–2.40) 0.05
E. coli, Escherichia coli; NS, not significant; UTI, urinary tract infection.
Note: Comparisons of chemokines between the different patient groups using Mann–Whitney test.
aChemokine concentrations were measured in 183 urine samples from 47 patients, taken during the first 24 h after admission to hospital due to febrile UTI.
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MyD88-dependent pathway leads directly to nuclear factor-
kB activation.33 The adaptor protein usage might thus
contribute to the differences in chemokine repertoire
observed in this study.
Chemokine transcription is further complicated by the
fact that maximal transcription involves the generation of
several transcription factors. For example, CXCL8 secretion is
mainly regulated at the transcriptional level where the
transcription factor nuclear factor-kB is essential for induc-
tion and the transcription factors activator protein-1 and
C/EBP are required for maximal gene expression.34–38 In this
study, chemokine secretion in response to papþ strains was
lower and more diverse including CXCL8, CCL2, and CCL5,
whereas the fimþ strain stimulated higher CXCL1 and
CXCL8 responses. This difference was supported at the
mRNA level. The results are consistent with the notion that
fimbriae might influence signal transduction pathways and
differentially regulate the transcription of chemokine genes.
Interesting differences in chemokine response repertoire
were also noted between P fimbrial types. Class II (papþ ) P
fimbriae predominate among acute pyelonephritis isolates
and recognize all Gala1-4Galb-containing oligosaccharides
and, consequently, all members of the globoseries of glyco-
sphingolipids.39 These fimbriae stimulated high CCL2
responses. Class III P fimbriae (prsþ ) are less prevalent
among pyelonephritis isolates and recognize N-acetyl-galac-
tosamine a-linked to a globoseries core.39,40 These fimbriae
triggered higher CCL5 responses than the papþ strain. The
same association with the papG genotype was observed in the
patients with febrile UTI.
We observed an association between the chemokine
repertoire and disease severity. The CCL2 concentrations
were higher in patients with symptoms of acute pyelone-
phritis, whereas CCL5 secretion was higher in patients with
symptoms from the lower urinary tract. This difference is in
agreement with the effect of P fimbriae, as acute pyelone-
phritis isolates carried the papþ sequences, whereas the
prsþ strains mostly caused lower tract symptoms. The
findings are consistent with a role of fimbriae as host
response modulators in vivo, and support the hypothesis that
iso-receptor variants, which bind closely related adhesins
may trigger different aspects of the epithelial chemokine
response. In addition, other cell types including neutrophils
are likely to contribute to the complex in vivo response. These
results illustrate how fimbriae and their receptors may
influence the chemokine profile of the infected mucosa.
The results infer that the inflammatory cell infiltrate might
vary with the fimbriae of the infecting strain. Type 1
fimbriated strains were shown to mainly stimulate neutro-
phil-attracting chemokines which utilize CXCR1 and CXCR2
to mediate cellular responses.41 In contrast, the UPEC isolate
and the P fimbriated recombinants triggered chemokines
known to be potent monocyte chemoattractants,8 suggesting
that they also might stimulate a monocytic infiltrate after the
first wave of neutrophils. This is consistent with the severity
of infection due to P fimbriated E. coli, and the need for
prolonged host defense. However, recently the receptors for
CCL2 and CCL5 were shown to be expressed also on
neutrophils.42,43 Furthermore, Gouwy et al.44 demonstrated
that neutrophils achieve maximal chemotaxis with low levels
of the chemokine CCL2 together with moderate levels of
CXCL8, suggesting that this combination might be the
optimal stimulus of the anti-bacterial neutrophil effect and
thus for the defense of the urinary tract. The kinetics of
mRNA and protein secretion confirmed that CXCL8 and
CCL2 were the first mRNAs to increase, suggesting that a
combination of these chemokines is important during the
acute phase of the infection. Through such complex
mechanism, epithelial cells may regulate chemokine secretion
in response to pathogens and control leukocyte recruitment
to infected mucosal sites.
MATERIALS AND METHODS
Bacteria
E. coli Hu734 (serotype O75:K5:H, hlyþ , ColVþ ), a lac mutant of
E. coli GR12 isolated from a patient with acute pyelonephritis and
express type 1 and P fimbriae. It was maintained as describe
previously.19
The E. coli K-12 strain HB101 (pap) was used as a host for
recombinant plasmids encoding different P fimbrial variants.
Plasmid pDC1 carries the pap gene cluster from E. coli IA2 in the
BamHI site of pACY184.45 The plasmid pJFK carries the prs gene
cluster from E. coli J96 inserted in the BamHI site of pACYC184.39
These recombinant strains were designated as papþ or prsþ ,
respectively. The E. coli K-12 strain AAEC191A (fim) was used as a
host for recombinant plasmids encoding different type 1 fimbrial
variants. The plasmid pPKL4 carries the entire fim gene cluster from
E. coli PC31 in the Tet site of PBR322.46 The plasmid pPKL114 is
identical but with a stop-linker inserted into the KpnI site of the
fimH gene.47 Plasmid pBR322 was used as a vector control.48 These
recombinant strains were designated as fimþ and fimH. The
strains were cultured, harvested, and re-suspended in Roswell’s Park
Memorial Institute medium to a final concentration of 108 CFU/ml,
as described previously.19
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Figure 5 | CCL2 response in febrile UTI patients in relation to pap
genotypes of the infecting E. coli. The median CCL2 during the first
24 h is shown for the total patient population (n¼ 73), with
differences between the papG allelic groups marked in the figure
(E¼ papþ E. coli, n¼ prsþ E. coli, ’¼ pap E. coli). Po0.01 for
comparison a, h; Po0.05 for comparison b, c, d, e, f, g.
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Preparation of epithelial cell layers
A498 kidney epithelial cells (ATCC no. HTB44) were cultured in
Roswell’s Park Memorial Institute medium 1640 (Invitrogen,
Stockholm, Sweden) supplemented with 0.05 mg/ml gentamycin
(Invitrogen), 2 mM glutamine, and 5% fetal calf serum (Difco,
Detroit, MI, USA), with change of medium every third day. The cells
were detached by phosphate-buffered saline/ethylenediaminetetraa-
cetic acid treatment (0.2 g ethylenediaminetetraacetic acid, 5 g NaCl,
0.25 g KCl, 1.78 g Na2HPO4 2H2O, 0.25 g KH2PO4, 1 l H2O).
Confluent A498 epithelial cell layers were prepared on Transwell
(Costar, Cambridge, MA, USA) inserts as described previously.49
Chemokine secretion by stimulated epithelial cells
Chemokine secretion by the A498 cells was quantified by enzyme-
linked immunosorbent assay as described.50 Medium was obtained
from the upper and lower wells of E. coli stimulated cell layers at
different time points and kept at 201C until used.
RNase protection assay
A498 cells were cultured in 75 m2 culture flasks for 4 days, detached
by phosphate-buffered saline/ethylenediaminetetraacetic acid treat-
ment as described, harvested by centrifugation 150 g for 5 min,
washed with repeated cycles of centrifugation, and re-suspended in
phosphate-buffered saline. The cell concentration was adjusted to
105 ml1 as counted in a Bu¨rker chamber. Bacteria were cultured as
described, mixed with the epithelial cell suspension (final concen-
tration, 106 cells and 109 bacteria ml1) for 2 or 24 h. Total epithelial
RNA was isolated using TRIzol (Invitrogen). CXC chemokines
(CXCL8, CXCL10), CC chemokines (CCL5, CCL3, CCL4), C
chemokine (XCL1), and the two housekeeping genes L32 and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) RNAs were
quantified using the RiboQuant Multi-Probe RNase Protection
Assay (Becton Dickinson, Stockholm, Sweden) as described
previously.51 The products were quantified in a PhosphorImager
STORM 840 (GE Healthcare, Uppsala, Sweden) with the Image-
Quant software package (GE Healthcare). Values obtained for
CXCR1 mRNA levels were normalized against the corresponding
values for glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Chemokine analysis in vivo
Urine samples were obtained from 73 patients prospectively enrolled
between 1991 and 1994 in a study of patients with febrile UTI.52 The
patients were between 18 and 85 years old, with febrile UTI
requiring hospitalization, and parenteral antibiotic therapy. The
patients assigned to the compromised group had diabetes, chronic
lymphocytic leukemia, systemic lupus erythematodes, alcoholism,
Morbus Crohn, cancer, treatment with corticosteroids, or urinary
tract abnormalities. Patients with urinary tract abnormalities had
prostatic hyperplasia, operations of the urogenital tract, renal stones,
prolapse of the uterus, urinary tract devices, indwelling urinary
catheter, intermitted catheterization, or an artificial urinary
sphincter. Focal symptoms from the upper urinary tract included
flank pain, costo-vertebral angle tenderness and symptoms from the
lower urinary tract included dysuria, frequency, and suprapubic
pain. Chemokine concentrations were measured in 183 urine
samples taken during the first 24 h after admission to the hospital
and the chemokine content was quantified in urine by enzyme-
linked immunosorbent assay. Semiquantitative urine cultures were
obtained at the time of diagnosis, and the infecting strain was saved
as deep agar stabs. The papG genotype of the infecting E. coli strains
was analyzed by polymerase chain reaction as described previously.52
The study was approved by the research ethics committee of the
Medical Faculty at the University of Lund.
Statistical analysis
One-way analysis of variance and Bonferroni multiple comparisons
test, the Mann–Whitney U-test (two-tailed), and Wilcoxon’s test
were used to compare the experimental groups.
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